Botanic Healthcare Expands Ethical Berberine Production Amid Rising Demands
Hyderabad, 18 March 2025 – Botanic Healthcare, a global leader in the nutraceutical sector and a manufacturer and exporter of premium herbal extracts, reinforces its commitment to sustainability by ethically sourcing and producing Berberis aristata (Kashmal). The company’s trademark products, BerBix™ and BERMAX™, reflect its dedication to environmentally responsible operations while strengthening regional economies and contributing to the global herbal market.
The company has signed an Access and Benefit Sharing (ABS) agreement with the Himachal Pradesh Department of Biodiversity, ensuring sustainable and legal extraction practices. Recognized for its role in regulating blood sugar, improving lipid metabolism, and enhancing cardiovascular health, BerBix™ is a key offering in the company’s product portfolio. Complementing this is BERMAX™, an advanced liposomal berberine formulation designed to improve bioavailability and absorption.
Established in 2013, Botanic Healthcare is driving the global recognition of Indian Ayurveda through innovative nutraceutical formulations. Its manufacturing facility in Bilaspur, Himachal Pradesh, specializes in extracting Berberis aristata, valued for its bioactive alkaloid, berberine, known for multiple health benefits.
Committed to sustainability, the company adheres to the Access and Benefit Sharing (ABS) framework, ensuring the legal and responsible extraction of Berberis aristata while paying required ABS fees to support biodiversity conservation.
Botanic Healthcare’s BerBix™ is a high-purity berberine extract (70% and 97% berberine hydrochloride) that meets stringent EU and USP standards. BERMAX™, an advanced liposomal berberine, undergoes rigorous testing for stability, ensuring optimal absorption and efficacy.
Supporting over 1,000 farmers in Himachal Pradesh’s Mandi and Barot valleys, the company sources approximately 8,000 MT of raw material annually, guaranteeing fair pricing and employment opportunities while reinforcing its commitment to environmental and socio-economic sustainability.
“As the global demand for berberine-based products continues to rise, with projections estimating the market to reach USD 4.22 billion by 2033, Botanic Healthcare is strategically positioned to capitalize on this expanding opportunity. Our flagship products, BerBix™ and BERMAX™, are integral to shaping the future of India’s herbal industry,” said Mr. Gaurav Soni, Founder & Managing Director of Botanic Healthcare.
“At Botanic Healthcare, we remain committed to sustainability and responsible sourcing, adhering to legal and ethical practices. By doing so, we not only contribute to the global health market but also foster the long-term growth and global competitiveness of India’s herbal industry,” added Mr. Madhu Krishnamani, Founder and Managing Director of Botanic Healthcare.